Track topics on Twitter Track topics that are important to you
After last year's rollercoaster ride, the job market for college graduates has settled down and appears braced for slow but steady growth, according to a new study.
Naarden, The Netherlands, 17 November 2011 - Forbion Capital Partners today announces that it has invested in Oxyrane UK Limited, a biopharmaceutical company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than forty rare inherited diseases. In its oversubscribed Series D financing round the company raised $26.5m. Other i...
Leiden, The Netherlands, 17 November 2011 – Prosensa, the Dutch company focusing on RNA modulating therapeutics for rare diseases with unmet medical needs, has been granted two new patents for exon-skipping by the Japanese Patent Office and the United States Patent and Trademark Office, and has confirmed its strong position in Europe during an opposition procedure which was concluded ye...
GlaxoSmithKline (GSK) today welcomes the European Commission’s commitment to promote collaborative research efforts to develop new antibiotics against the growing threat from resistant bacteria.
GlaxoSmithKline today welcomed the decision of the GAVI Board to provide funding to facilitate the provision of cervical cancer immunisation programmes and rubella vaccination, across the world's poorest countries.
A new study has found that protein and not sugar activates the cells responsible for keeping us awake and burning calories. The research has implications for understanding obesity and sleep disorders.
A man with a low IQ confesses to a gruesome crime. Confession in hand, the police send his blood to a lab to confirm that his blood type matches the semen found at the scene. It does not. The forensic examiner testifies later that one blood type can change to another with disintegration. This is untrue. The newspaper reports the story, including the time the man says the murder took place. Two wit...
Aging and health issues facing lesbian, gay, bisexual and transgender baby boomers have been largely ignored by services, policies and research. These seniors face higher rates of disability, physical and mental distress and a lack of access to services, according to the first study on aging and health in these communities.
16 November 2011; Chester, UK: Building on the success of previous years, a record number of delegates from seven different countries attended the latest Filtration Society two-day technical meeting. Held at the Ramada Hotel in Chester, UK in October, Filter Media 5 was the fifth international event focused on filter media and combined a training session, conference and exhibition. Pr...
e-HAP FYI—one of a series of new communication products that expands the Division of HIV/AIDS Prevention's (DHAP) ability to reach you with timely, targeted information critical to our collective prevention efforts.
Ruggell, Liechtenstein, 16th November 2011 - Pantec Biosolutions AG, a privately-owned company developing innovative dermal drug delivery products, will present its recently launched P.L.E.A.S.E.® Professional laser device at the MEDICA International Trade Fair from 16-19 November in Düsseldorf, Germany. Pantec Biosolutions’ P.L.E.A.S.E.® Professional is the world’s f...
Alcoholic brains can perform a simple finger-tapping exercise as well as their sober counterparts but their brain must work a lot harder to do it, according to a new study.
Head-to-head study primary end point did not meet non-inferiority, but results support progression towards registration
In this episode of PharmaTelevision News Review, Fintan Walton talks to Graham Anthouny, CFO of BioVista Inc.
In this episode of PharmaTelevision News Review, Paul Larsmon talks to Claire Skentelbery, Secretary General of European Biotechnology Network.
New research identifies the brain chemicals and circuits involved in mental illnesses like schizophrenia, depression, and anxiety, giving potential new directions to their treatment. In addition, research with children shows that early-life depression and anxiety changes the structure of the developing brain.
Students with cognitive impairments may learn to comprehend written texts much better than commonly thought, according to researchers in Sweden.
Getting enough sleep can help children maintain a healthy weight, new research reveals. Similarly, the more time children spend in front of the TV or their computers (screen time), the higher their body weight.
After only four years of problem drinking, a significant decrease in the function of the serotonin system in women’s brains can be seen. This is the system that regulates such functions as impulse control and mood. It takes 12 years before a corresponding decrease is seen in men.
People who are alcohol-dependent and who also carry a particular variant of a gene run an increased risk of premature death, according to research from Sweden.
In 1972, Sweden became the first country in the world to legislate healthcare for transsexualism within the state-financed healthcare system. In an international perspective, this was considered to be radical. It was expected that the life situation of people in the transsexual group would improve, now that state-financed healthcare was available for this group. New research from Sweden, however, ...
Groundbreaking research provides new insight into how the brain perceives color.
For decades, scientists have dreamed of building computer systems that could replicate the human brain's talent for learning new tasks. Researchers have now taken a major step toward that goal by designing a computer chip that mimics how the brain's neurons adapt in response to new information. This phenomenon, known as plasticity, is believed to underlie many brain functions, including learning a...
Oxford, UK, 15 November 2011 – Midatech Ltd., a global leader in the design, development, synthesis and manufacture of nanomedicines, announced today it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG. The trial is designed to assess the safety profile...
Revascor™, Mesoblast’s proprietary Mesenchymal Precursor Cell (MPC) product for cardiovascular diseases, was safe and well-tolerated at all doses, with no clinically relevant immune responses to donor cells Revascor™ therapy significantly reduced cardiac mortality and major adverse cardiac events (MACE) in patients with congestive heart failure over a mean follow-up o...
BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.